4153011000036102: Xylocard (trade product)
Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Expanded Value Set
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Xylocard 10% (500 mg/5 mL) injection, 5 mL ampoule |
Is a |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 10% (500 mg/5 mL) injection, 10 x 5 mL ampoules |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 10% (500 mg/5 mL) injection, 10 x 5 mL ampoules |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 2% (100 mg/5 mL) injection, 5 mL ampoule |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 2% (100 mg/5 mL) injection, 2 x 5 mL ampoules |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 2% (100 mg/5 mL) injection, 5 mL ampoule |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 2% (100 mg/5 mL) injection, 5 x 5 mL ampoules |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 2% (100 mg/5 mL) injection, 5 x 5 mL ampoules |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard 2% (100 mg/5 mL) injection, 2 x 5 mL ampoules |
has TP |
True |
Xylocard |
Inferred relationship |
Some |
|
Xylocard (lidocaine hydrochloride 100 mg / 5 mL) injection, 5 mL ampoule (trade product unit of use) |
Is a |
True |
Xylocard |
Inferred relationship |
Some |
|
Reference Sets
Trade product reference set
Back to Start